Oddo BHF Asset Management Sas Boosts Stock Holdings in Cigna Group $CI

Oddo BHF Asset Management Sas grew its position in shares of Cigna Group (NYSE:CI) by 28.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 12,115 shares of the health services provider’s stock after buying an additional 2,710 shares during the quarter. Oddo BHF Asset Management Sas’ holdings in Cigna Group were worth $3,334,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also recently made changes to their positions in the company. Banco Bilbao Vizcaya Argentaria S.A. raised its position in Cigna Group by 13.5% in the 3rd quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 34,114 shares of the health services provider’s stock worth $9,839,000 after buying an additional 4,066 shares during the last quarter. Compass Wealth Management LLC purchased a new position in shares of Cigna Group in the 3rd quarter worth $4,718,000. Alberta Investment Management Corp purchased a new position in shares of Cigna Group in the 3rd quarter worth $3,171,000. Distillate Capital Partners LLC boosted its stake in shares of Cigna Group by 19.1% in the 3rd quarter. Distillate Capital Partners LLC now owns 108,676 shares of the health services provider’s stock worth $31,338,000 after buying an additional 17,442 shares during the last quarter. Finally, Colrain Capital LLC boosted its stake in shares of Cigna Group by 106.4% in the 3rd quarter. Colrain Capital LLC now owns 22,500 shares of the health services provider’s stock worth $6,486,000 after buying an additional 11,600 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Analyst Ratings Changes

CI has been the topic of a number of research reports. Deutsche Bank Aktiengesellschaft downgraded Cigna Group from a “buy” rating to a “hold” rating and dropped their price target for the stock from $303.00 to $302.00 in a research note on Wednesday, May 20th. Barclays cut shares of Cigna Group from an “overweight” rating to an “equal weight” rating and reduced their target price for the company from $310.00 to $304.00 in a report on Tuesday, May 26th. Wells Fargo & Company upped their target price on shares of Cigna Group from $300.00 to $305.00 and gave the company an “equal weight” rating in a report on Friday, May 1st. Sanford C. Bernstein upped their target price on shares of Cigna Group from $358.00 to $371.00 and gave the company an “outperform” rating in a report on Tuesday, May 5th. Finally, Morgan Stanley upped their target price on shares of Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a report on Wednesday, May 20th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat.com, Cigna Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $338.30.

Insiders Place Their Bets

In other news, CEO David Cordani sold 201,878 shares of the business’s stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the transaction, the chief executive officer owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. The trade was a 85.46% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the transaction, the chief accounting officer directly owned 2,368 shares in the company, valued at $707,108.48. This trade represents a 27.52% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 0.60% of the company’s stock.

Cigna Group Stock Down 0.6%

CI stock opened at $292.01 on Wednesday. Cigna Group has a twelve month low of $239.51 and a twelve month high of $338.89. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69. The stock has a market cap of $77.25 billion, a P/E ratio of 12.38, a PEG ratio of 1.13 and a beta of 0.28. The business’s 50-day moving average price is $283.44 and its 200-day moving average price is $278.26.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The business had revenue of $68.52 billion during the quarter, compared to analyst estimates of $66.29 billion. During the same quarter in the prior year, the business posted $6.74 EPS. Cigna Group’s revenue for the quarter was up 4.6% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, equities research analysts forecast that Cigna Group will post 30.39 EPS for the current year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be paid a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date is Thursday, June 4th. Cigna Group’s dividend payout ratio is presently 26.45%.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.